Page last updated: 2024-10-29

ioversol and Canine Diseases

ioversol has been researched along with Canine Diseases in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Ioxilan has the least arrythmogenic property among the current low-osmolality nonionic CMs."5.31The risk of contrast media-induced ventricular fibrillation is low in canine coronary arteriography with ioxilan. ( Fujiki, M; Misumi, K; Miura, N; Sakamoto, H; Tateno, O, 2000)
"Ioxilan has the least arrythmogenic property among the current low-osmolality nonionic CMs."1.31The risk of contrast media-induced ventricular fibrillation is low in canine coronary arteriography with ioxilan. ( Fujiki, M; Misumi, K; Miura, N; Sakamoto, H; Tateno, O, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Misumi, K1
Tateno, O1
Fujiki, M1
Miura, N1
Sakamoto, H1

Other Studies

1 other study available for ioversol and Canine Diseases

ArticleYear
The risk of contrast media-induced ventricular fibrillation is low in canine coronary arteriography with ioxilan.
    The Journal of veterinary medical science, 2000, Volume: 62, Issue:4

    Topics: Animals; Contrast Media; Coronary Angiography; Dog Diseases; Dogs; Female; Iohexol; Iopamidol; Male;

2000